in this issue
Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients
CPhI: Saltigo Develops Generic Pharmaceuticals Strategy
12:53 AM MDT | October 26, 2009 | Deepti Ramesh in Madrid
Saltigo, the custom synthesis and manufacturing services subsidiary of Lanxess, says the business is trying to develop strategies for manufacturing generic drugs for its pharma customers. Additionally, the business says that in future there will be more alliances between pharmaceutical contract manufacturers. “Custom manufacturing companies with different expertise such as those with expertise in technology and with lower cost platforms will form more alliances in the future,” Andreas Stolle, head of the pharma business line pharma at Saltigo, tells...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee